CD4 and hepatocellular carcinoma: For all these reasons, elevated levels of circulating CD4+ CD25+ FoxP3+ Tregs are associated with tumor progression and reduced survival rates in patients affected by hepatocellular carcinoma [125], and the FOXP3+ Treg/CD4+ T-cell ratio also serves as a prognostic indicator for overall survival [126].